# Allevi

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/allevi

- Industry: Medical Devices & Equipment
- Headquarters: Philadelphia, US
- Website: www.allevi3d.com
- Total disclosed funding: $2M
- Latest round: Series A (Oct 30, 2019)
- Investors on record: 2

## About

Allevi, Inc. develops advanced 3D bioprinting technologies, specializing in bioprinters and bioinks that empower innovative research in tissue engineering and regenerative medicine.Founded in 2014, Allevi, Inc. is headquartered in Philadelphia, US. The company focuses on 3D bioprinting solutions designed for biomedical applications. Allevi raised USD 2.000 mn in Series A funding on October 30, 2019, from investors including Alumni Ventures Group and Space Angels. CEO Frank McCaney leads the company, which has executed one deal to date.Allevi specializes in advanced 3D bioprinting technologies, offering a range of bioprinters such as Allevi 1, Allevi 2, and Allevi 3, equipped with patented Core Printheads (CORE™) to optimize cell viability. Their bioinks, including Lifeink® and GelMA, facilitate the creation of functional tissue structures. The company distributes its products across North America, Europe, and parts of Asia, serving academic institutions, research laboratories, and biotechnology firms.Allevi generates revenue through direct sales of bioprinters, bioinks, and related consumables, engaging in B2B transactions primarily with research institutions and biotech firms. Customers can purchase products outright, while also benefiting from support for product integration into existing workflows. The company's consumables, such as syringes and nozzles for bioprinters, create a steady revenue stream from clients who require ongoing supplies.Allevi plans to utilize the USD 2.000 mn raised in Series A funding to enhance its product offerings and expand into new markets. The company is focused on launching upgraded bioprinter models and developing new bioink formulations by the end of 2021. Expansion efforts will target additional regions in Europe and Asia, aiming to establish a more significant presence in these markets by 2023.

## Funding rounds

- Series A, Oct 30, 2019, $2M — Alumni Ventures Group, Space Angels

## Investors

- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series A
- Space Angels (https://capitalatlas.ai/funds/space-angels) — Series A